Position in GPCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$63,062,250
+$6,427,250 QoQ
Shares Held
1,175,000
0.0% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
3.16%
of 13F equity value
Holder Rank
#14
of 191 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Dec 31, 2023CallValue
$1,019,000
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Casdin Capital, LLC holds $1,258,350,419 across 31 Biotechnology names. GPCR ranks #3 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $482,682,924 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
16,035,240 | $300,019,340 | |
| 3 | GPCR |
Structure Therapeutics Inc.
This page
|
1,175,000 | $63,062,250 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,045,000 | $52,597,400 | |
| 5 | NGNE |
Neurogene Inc.
|
1,545,361 | $48,601,603 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $46,332,000 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
665,000 | $36,575,000 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
843,857 | $25,180,692 |
All Filings in GPCR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,062,250 | 1,175,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,635,000 | 1,175,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,721,250 | 1,175,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,540,000 | 1,555,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,406,500 | 1,225,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,117,000 | 700,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,984,000 | 700,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,723,000 | 700,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,489,000 | 700,000 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $47,868,919 | 1,116,867 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,019,000 | 25,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $44,504,498 | 1,091,867 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $63,436,729 | 1,258,166 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $41,445,996 | 997,017 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,106,234 | 677,017 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||